Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Lipocine Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +22 vs. Q4 2025
- Shares held
- 3.12M
- +1.71M (+121.5%) vs. Q4 2025
- Total value
- $24.9M
- +$13.6M (+120.3%) vs. Q4 2025
- New holders
- 24
- 9 more added
- Sold out
- 2
- 10 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 50 | $0 | 0.00% | −23−31.5% | Reduced |
| Farther Finance Advisors, LLC | 1 | $9 | 0.00% | +1 | New |
| Bogart Wealth, LLC | 3 | $24 | 0.00% | +3 | New |
| Tidemark, LLC | 59 | $471 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 67 | $535 | 0.00% | 00.0% | Unchanged |
| PlanVest Financial, Inc | 111 | $887 | 0.00% | +111 | New |
| Group One Trading, L.P. | 132 | $1.05K | 0.00% | −30−18.5% | Reduced |
| Advisor Group Holdings, Inc. | 143 | $1.14K | 0.00% | +25+21.2% | Added |
| JPMorgan Chase & Co | 392 | $2.97K | 0.00% | +392 | New |
| Caldwell Sutter Capital, Inc. | 471 | $3.76K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 574 | $4.59K | 0.00% | −177−23.6% | Reduced |
| FMR LLC | 626 | $5.00K | 0.00% | +549+713.0% | Added |
| Tower Research Capital LLC (TRC) | 933 | $7.46K | 0.00% | +933 | New |
| Vanguard Global Advisers, LLC | 1,691 | $13.5K | 0.00% | +1,691 | New |
| Wells Fargo & Company | 2,706 | $21.6K | 0.00% | +2,706 | New |
| UBS Group AG | 3,494 | $27.9K | 0.00% | −2,109−37.6% | Reduced |
| Barclays PLC | 9,412 | $75.2K | 0.00% | +9,412 | New |
| Ameriprise Financial Inc | 11,448 | $91.5K | 0.00% | −4,656−28.9% | Reduced |
| Prelude Capital Management, LLC | 12,630 | $100.9K | 0.01% | +12,630 | New |
| Northern Trust Corp | 13,042 | $104.2K | 0.00% | −118−0.9% | Reduced |
| Persistent Asset Partners Ltd | 13,442 | $107.4K | 0.04% | −57,134−81.0% | Reduced |
| XTX Topco Ltd | 17,923 | $143.2K | 0.00% | +17,923 | New |
| Dimensional Fund Advisors LP | 19,122 | $152.8K | 0.00% | +6,982+57.5% | Added |
| Jane Street Group, LLC | 20,027 | $160.0K | 0.00% | +9,453+89.4% | Added |
| State Street Corp | 22,407 | $179.0K | 0.00% | +3,781+20.3% | Added |
| ADAR1 Capital Management, LLC | 23,180 | $185.2K | 0.01% | +23,180 | New |
| Susquehanna International Group, LLP | 24,908 | $199.0K | 0.00% | −10.0% | Reduced |
| Citadel Advisors LLC | 29,088 | $232.4K | 0.00% | +29,088 | New |
| Vanguard Fiduciary Trust Co | 32,413 | $259.0K | 0.00% | +32,413 | New |
| Two Sigma Investments, LP | 33,750 | $269.7K | 0.00% | +33,750 | New |
| Renaissance Technologies LLC | 38,497 | $307.6K | 0.00% | +1,100+2.9% | Added |
| J. Goldman & Co LP | 42,170 | $336.9K | 0.02% | +42,170 | New |
| Diadema Partners LP | 50,000 | $399.5K | 0.16% | −210,939−80.8% | Reduced |
| Exome Asset Management LLC | 60,861 | $486.3K | 0.29% | +60,861 | New |
| Geode Capital Management, LLC | 63,135 | $504.7K | 0.00% | +685+1.1% | Added |
| Mink Brook Asset Management LLC | 66,812 | $533.8K | 0.30% | +66,812 | New |
| BlackRock, Inc. | 89,272 | $713.3K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 111,786 | $893.2K | 0.51% | +111,786 | New |
| Seven Fleet Capital Management LP | 124,942 | $998.3K | 0.31% | +124,942 | New |
| Boothbay Fund Management, LLC | 140,487 | $1.12M | 0.03% | +85,594+155.9% | Added |
| StemPoint Capital LP | 160,420 | $1.28M | 0.25% | +160,420 | New |
| AIGH Capital Management LLC | 200,000 | $1.60M | 0.33% | +200,000 | New |
| Vanguard Capital Management LLC | 200,668 | $1.60M | 0.00% | +200,668 | New |
| Rosalind Advisors, Inc. | 221,616 | $1.77M | 0.73% | +221,616 | New |
| Eversept Partners, LP | 294,989 | $2.36M | 0.16% | +294,989 | New |
| Squadron Capital Management LLC | 450,000 | $3.60M | 1.44% | −80,000−15.1% | Reduced |
| Ikarian Capital, LLC | 508,556 | $4.06M | 0.58% | +309,014+154.9% | Added |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |